Clinical Trial Update: Moxidectin for LF, Cote d'Ivoire (DOLF) [Phase 3]

View source ↗

Summary

Phase 3 trial results for moxidectin in lymphatic filariasis completed in Côte d'Ivoire, with results posted January 29, 2026.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphatic Filariasis

Drugs mentioned

• Moxidectin (moxidectin)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Lymphatic Filariasis | Phase 3 | Status: COMPLETED | Results posted: 2026-01-29